Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

514 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The origin of prostate metastases: emerging insights.
Santoni M, Piva F, Scarpelli M, Cheng L, Lopez-Beltran A, Massari F, Iacovelli R, Berardi R, Santini D, Montironi R. Santoni M, et al. Among authors: scarpelli m. Cancer Metastasis Rev. 2015 Dec;34(4):765-73. doi: 10.1007/s10555-015-9597-6. Cancer Metastasis Rev. 2015. PMID: 26363603 Review.
Metabolic Alterations in Renal and Prostate Cancer.
Ciccarese C, Santoni M, Massari F, Modena A, Piva F, Conti A, Mazzucchelli R, Cheng L, Lopez-Beltran A, Scarpelli M, Tortora G, Montironi R. Ciccarese C, et al. Among authors: scarpelli m. Curr Drug Metab. 2016;17(2):150-5. doi: 10.2174/1389200216666151015112356. Curr Drug Metab. 2016. PMID: 26467063 Review.
Emerging Immunotargets and Immunotherapies in Prostate Cancer.
Montironi R, Santoni M, Sotte V, Cheng L, Lopez-Beltran A, Massari F, Matrana MR, Moch H, Berardi R, Scarpelli M. Montironi R, et al. Among authors: scarpelli m. Curr Drug Targets. 2016;17(7):777-82. doi: 10.2174/1389450117666160217123304. Curr Drug Targets. 2016. PMID: 26898309 Review.
Urinary Biomarkers for Prostate Cancer.
Giunchi F, Ciccarese C, Montironi R, Scarpelli M, Lopez-Beltran A, Cheng L, Moch H, Massari F, Fiorentino M. Giunchi F, et al. Among authors: scarpelli m. Curr Drug Metab. 2017 Oct 16;18(8):723-726. doi: 10.2174/1389200218666170518161140. Curr Drug Metab. 2017. PMID: 28524004 Review.
Circulating Tumor Cells: A Reliable Biomarker for Prostate Cancer Treatment Assessment?
Ciccarese C, Montironi R, Fiorentino M, Martignoni G, Brunelli M, Iacovelli R, Lopez-Beltran A, Cheng L, Scarpelli M, Moch H, Tortora G, Massari F. Ciccarese C, et al. Among authors: scarpelli m. Curr Drug Metab. 2017;18(8):692-699. doi: 10.2174/1389200218666170518163549. Curr Drug Metab. 2017. PMID: 28524006 Review.
PD-L1 Inhibitors for the Treatment of Prostate Cancer.
Santoni M, Massari F, Cheng L, Cimadamore A, Scarpelli M, Montironi R, Lopez-Beltran A. Santoni M, et al. Among authors: scarpelli m. Curr Drug Targets. 2020;21(15):1558-1565. doi: 10.2174/1389450121666200609142219. Curr Drug Targets. 2020. PMID: 32516098 Review.
514 results